Parmax Pharma Limited informed that the board of directors of the company at its meeting held on October 9, 2018, inter alia transacted the following Businesses: Board of Directors has accepted the resignation of Ms. Isha Shrotriya from the post of Company Secretary and Compliance Officer of the company with effect from October 7, 2018. The Board has approved the appointment of Mr. Yash Vora as Company Secretary Cum Compliance Officer of the company with effect from October 8, 2018.